logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
N

Nan Bi

chinese academy of medical sciences and peking union medical college

36H指数
427论文数
5.2K被引数
收录论文 191
发表时间
logo
Early stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precision早期非小细胞肺癌：在生物精准时代迈向风险适应性范式
errCA-A Cancer Journal for Clinicians
IF232.4
err2026-09-10
err0
errOAAI
errChaoqi Zhang MD, PhD; Xuanyu Gu MD; Pan Wang MD; Dongyu Li MD; Guochao Zhang MD; Ting Wang MD, PhD; Peng Wu PhD; Wei Rao MD; Shan Muhammad PhD; Binghua Tan MD; Yun Che MD, PhD; Mobai Zhu MD; Qilin Qiao MD; Fanbo Lai MD; Bohui Zhao MD; Kailun Fei MD; Yue Wu PhD; Zhihui Zhang PhD; Min Dai PhD; Wanqing Chen MD, PhD; Yawei Zhang PhD; Nan Bi MD; Jie Wang MD; Jie He MD, PhD
err分享
err收藏
Peripheral PD-1⁺CD8⁺ T-cell TCR Dynamics During Radiation Therapy Predict Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer外周PD-1⁺CD8⁺ T细胞TCR动力学在放射治疗期间可预测不可切除局部晚期非小细胞肺癌的生存期
errInternational Journal of Radiation Oncology*Biology*Physics
IF0
err2026-05-16
err0
PREAI
errYing Jiang; Yin Yang; Linfang Wu; Jianyang Wang; Yuqi Wu; Xin Wang; Haoyan Wang; Jing Bai; Xuefeng Xia; Zhijie Wang; Lei Zhang; Nan Bi
err分享
err收藏
The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta-Analysis在不可切除癌症中，化疗联合免疫检查点抑制剂与巩固性免疫检查点抑制剂同期添加：一项系统评价和Meta分析
errInternational Journal of Cancer
IF4.7
err2026-05-14
err0
errOAAI
errXu Tong; Zhenting Liu; Xiaoxiang Zhou; Nan Bi; Yibo Gao
err分享
err收藏
Comparing the Prognosis of Non-Small Cell Lung Cancer Patients Who Did Not Undergo Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy: A Retrospective Study比较新辅助化疗联合免疫治疗后未行手术的非小细胞肺癌患者的预后：一项回顾性研究
errThoracic Cancer
IF2.3
err2026-04-10
err0
errOAAI
errMa, Zhenghui; Wu, Yuqi; Ji, Guangqian; Zhou, Zongmei; Wang, Xin; Wang, Jianyang; Liu, Wenyang; Deng, Lei; Wang, Wenqing; Yi, Junlin; Bi, Nan; Zhang, Tao
err分享
err收藏
Interpretable deep learning model of circulating genomics for quantitative survival prediction in advanced non-small cell lung cancer循环基因组定量生存预测的可解释深度学习模型在晚期非小细胞肺癌中的应用
errClinical and Translational Oncology
IF2.5
err2026-02-06
err0
PREAI
errYu Wang; Yi-Tong Li; Ming-Hao Wang; Cheng-Yi Zhang; Ying Jiang; Qi Xu; Ying-Ping Liu; Can-Jun Li; Ye-Xiong Li; Nan Bi
err分享
err收藏
In Reply to Noguchi et al
errInternational Journal of Radiation Oncology*Biology*Physics
IF0
err2026-02-03
err0
PREAI
errYingming Zhu; Jinghao Duan; Wei Jiang; Wenqing Wang; Ying Jiang; Huiyao Huang; Jianzhong Cao; Nan Bi
err分享
err收藏
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancerPRIME: 基于液体活检的可解释人工智能模型可改善非小细胞肺癌进展风险的预测
errMilitary Medical Research
IF22.9
err2026-01-06
err0
errOAAI
errYu Wang; Yong-Bo Xiang; Xiao-Wei Chen; Tao Zhang; Jian-Yang Wang; Wen-Yang Liu; Lei Deng; Lu-Hua Wang; Shu-Geng Gao; Nan Bi
err分享
err收藏
Consensus on the Diagnosis and Treatment of Unresectable Stage III Driver Gene-Positive Non-Small Cell Lung Cancer不可切除III期驱动基因阳性非小细胞肺癌的诊断与治疗共识
errCancer Letters
IF10.1
err2025-12-17
err0
errOAAI
errXiangjiao Meng; Nan Bi; Jun Wang; Xue Meng; Jianbo Wang; Ligang Xing; Yufeng Cheng; Shun Lu; Ming Chen; Jinming Yu
err分享
err收藏
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trialS-1为基础的放化疗在不可手术的老年食管癌患者中的长期疗效：一项多中心、随机、III期临床试验
errRadiotherapy and Oncology
IF5.3
err2025-12-16
err0
PREAI
errJunqiang Chen; Xiao Chang; Wenyang Liu; Xiaomin Wang; Xiaolin Ge; Ke Liu; Lei Deng; Miaomiao Hu; Jianchao Lu; Wei Wang; Haiwen Zhou; Shuai Qie; Jihong Zhang; Weiming Han; Wenqing Wang; Zongmei Zhou; Xin Wang; Jun Liang; Nan Bi; Tao Zhang
err分享
err收藏
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapyPACIFIC-5: 在不可切除的III期NSCLC患者中巩固durvalumab的III期临床试验，同时或序贯放化疗后无进展
errJournal of Hematology & Oncology
IF40.4
err2025-12-07
err0
errOAAI
errYi-Long Wu; Lin Wu; Nan Bi; Timucin Cil; Hong Ge; Zhengfei Zhu; Chih-Liang Wang; Wei Zhang; Dongqing Lv; E. Mingyan; Jianguo Sun; Yi Pan; Maciej Krzakowski; Mustafa Dikilitas; Mehmet Ali Nahit Sendur; Young-Chul Kim; Yanjiao Yang; Rui Mao; Biao Zhang; Luhua Wang
err分享
err收藏
Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients✰III期非小细胞肺癌携带ALK重排的长期结局与临床特征：一项包含176例患者的多中心回顾性研究✰
errJournal of the National Cancer Center
IF9.4
err2025-11-27
err0
errOAAI
errFengwei Tan; Ying Jiang; Jianchun Duan; Renda Li; Jianzhong Cao; Wei Jiang; Qiang Li; Guochao Zhang; Jinghao Duan; Yu Wang; Zhijie Wang; Weihua Li; Jianming Ying; Jie Wang; Nan Bi; Jie He
err分享
err收藏
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial吡非尼酮治疗2级和3级放射性肺损伤：一项多中心、开放标签、随机、二期试验
errThe Lancet Oncology
IF0
err2025-11-06
err0
PREAI
errZan Hou; Baiqiang Dong; Qiwei Yao; Hualin Chen; Qiuju Shao; Minying Li; Jianyang Wang; Keying Chen; Zhengfei Zhu; Fang Peng; Shihong Wei; Xiao Hu; Jiancheng Li; Meilian Liu; Bin Xu; Siming Zheng; Nan Bi; Shuohan Zheng; Qingqing Xu; Biqi Chen; Chenfei Wu; Rui Li; Wei Chen; Xin Liu; Yuchen Tian; Xuan Li; Suping Guo; Lei Zhao; Yujia Zhu; Ling Cai; Qiaoqiao Li; Li Li; Huilan Zhang; Chen Hu; Luhua Wang; Qiwen Li; Baoqing Chen; Ming Chen
err分享
err收藏
Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients循环肿瘤DNA为局限期小细胞肺癌患者的巩固性免疫治疗提供优化方案
errSignal Transduction and Targeted Therapy
IF52.7
err2025-10-16
err0
errOAAI
errYin Yang; Yuqi Wu; Jingjing Zhao; Tao Zhang; Kailun Fei; Xiaotian Zhao; Lei Deng; Zhihui Zhang; Ying Jiang; Jianyang Wang; Wenyang Liu; Xin Wang; Song Wang; Hua Bao; Xue Wu; Minyi Zhu; Qiuxiang Ou; Wei Tang; Luhua Wang; Zhijie Wang; Nan Bi
err分享
err收藏
Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial术后放疗对完全切除并接受辅助化疗的pIIIA-N2非小细胞肺癌患者长期结局的影响（PORT-C）：一项单中心、随机、III期试验
erreClinicalMedicine
IF10
err2025-10-16
err0
errOAAI
errYu Men; Yongxing Bao; Nan Bi; Zongmei Zhou; Jun Liang; Jima Lv; Qinfu Feng; Zefen Xiao; Yan Wang; Junling Li; Jie Wang; Shugeng Gao; Jie He; Zhouguang Hui; Luhua Wang
err分享
err收藏
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial同步整合推量调强放射治疗联合或不联合同期化疗在食管鳞状细胞癌患者中的应用：一项多中心、开放标签、随机、III期临床试验
errInternational Journal of Cancer
IF4.7
err2025-10-15
err0
PREAI
errWeiming Han; Linrui Gao; Xiaomin Wang; Chen Li; Zongmei Zhou; Lei Deng; Wenqing Wang; Wenyang Liu; Xin Wang; Dongfu Chen; Qinfu Feng; Nan Bi; Tao Zhang; Jianyang Wang; Yirui Zhai; Yidian Zhao; Zefen Xiao; Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG)
err分享
err收藏
Gut microbiota predictive of the efficacy of consolidation immunotherapy and chemoradiotherapy toxicity in lung cancer肠道微生物组预测肺癌巩固性免疫疗法疗效及化放疗毒性
errMed
IF11.8
err2025-10-14
err0
errOAAI
errLinfang Wu; Yitong Li; Wenqing Wang; Lei Deng; Hong Ge; Ming Cui; Nan Bi
err分享
err收藏
Simultaneous Integrated Dose Reduction Radiotherapy Versus Conventional Fractionated Radiotherapy With Chemotherapy for Limited-Stage Small-Cell Lung Cancer in the Modern Treatment Era: a Phase III, Randomized Clinical Trial (SDR-RT trial)同步整合剂量降低放射疗法与常规分割放射疗法联合化疗治疗现代治疗时代局限期小细胞肺癌的随机III期临床试验（SDR-RT试验）
errInternational Journal of Radiation Oncology*Biology*Physics
IF0
err2025-10-14
err0
PREAI
errTian-You Zhan; Tao Zhang; Wen-Qing Wang; Lei Deng; Yi-Rui Zhai; Wen-Bin Yan; Xin Wang; Jian-Yang Wang; Wen-Yang Liu; Ming-Hui Li; Qin-Fu Feng; Ji-Ma Lv; Ze-Fen Xiao; Dong-Fu Chen; Jun-Ling Li; Lv-Hua Wang; Jun Liang; Hong Ge; Jian-Rong Dai; Kuo Men; Jun-Lin Yi; Chen Hu; Nan Bi; Ye-Xiong Li; Zong-Mei Zhou
err分享
err收藏
Interpretable artificial intelligence based on immunoregulation-related genes predicts prognosis and immunotherapy response in lung adenocarcinoma基于免疫调节相关基因的可解释人工智能预测肺腺癌的预后和免疫治疗反应
errFrontiers in Bioinformatics
IF3.9
err2025-09-27
err0
errOAAI
errMinghao Wang†; Yu Wang†; Yitong Li†; Chengyi Zhang; Canjun Li; Nan Bi
err分享
err收藏
Efficacy and safety of consolidative thoracic radiotherapy for Extensive-Stage Small-Cell lung cancer in the era of immunotherapy: A Real-World study免疫治疗时代下，广泛期小细胞肺癌巩固性胸腔放疗的疗效与安全性：一项真实世界研究
errLung Cancer
IF4.4
err2025-09-17
err0
PREAI
errChaonan Zhang; Wenqing Wang; Nan Bi; Jianyang Wang; Wenyang Liu; Tao Zhang; Xin Wang; Zefen Xiao; Jima Lv; Qinfu Feng; Lei Deng; Zongmei Zhou
err分享
err收藏
A nomogram for predicting the risk of chemoradiotherapy-associated thrombocytopenia in patients with esophageal cancer: a real-world cohort study预测食管癌患者化疗放疗相关性血小板减少风险的列线图：一项真实世界队列研究
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-09-01
err0
errOAAI
errJia-Xuan Yang; Si-Yu Zuo; Jie Yang; Lin-Rui Gao; Zong-Mei Zhou; Nan Bi; Qin-Fu Feng; Ji-Ma Lv; Lin Sun; Wen-Qing Wang; Lei Deng; Tao Zhang; Jian-Yang Wang; Wen-Cheng Zhang
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
王
王军 (Jun Wang)
H 指数: 222 · 论文数: 3.2K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
T
Theodore S. Lawrence
H 指数: 102 · 论文数: 1.3K
D
Dongxin Lin
H 指数: 90 · 论文数: 630
王鑫 封面图
王鑫 (Xin Wang)
H 指数: 88 · 论文数: 1.8K
查看更多